Andrew joined the Board of Alliance in 2006. He has held various senior positions in the pharmaceutical industry in the UK and USA having been Managing Director and Senior Vice-President of SmithKline Beecham Pharmaceuticals (now GlaxoSmithKline), Chief Executive of Cerebrus plc until its sale, and President of International Medical Marketing Services with Parexel International. Andrew is a  founder of Navitas BioPharma Consulting. He graduated in Natural Sciences from the University of Cambridge
pharmaceutical